The diagnostic ability of circulating FABP4 levels for predicting overall thalassemia-associated adverse metaflammation and subsequently cardiometabolic comorbidities was evaluated through ROC analysis, focusing on the area under the curves (AUC) for FABP4. The gene discussed is FABP4; the disease is thalassemia.